港股创新药概念午后走强 荣昌生物、中国生物制药涨超15%

Group 1 - The Hong Kong stock market's innovative drug concept saw a strong performance in the afternoon, with Rongchang Biopharmaceutical and China National Pharmaceutical Group rising over 15% [1] - Other companies such as Junshi Biosciences, Zhaoyan New Drug (603127), BeiGene, and Kelun Pharmaceutical (002821) also experienced gains exceeding 5% [1] - Investors can buy Hong Kong stocks through A-share accounts without the need for the Hong Kong Stock Connect, allowing for T+0 trading [1]